Arietis

Arietis is a Boston-based biotechnology company focused on the discovery and development of novel antimicrobial agents.

Copyright © 2016 Arietis Corporation - All Rights Reserved

PUBLICATIONS

 

 

 

Gavrish, E., B. Shrestha, C. Chen, I. Lister, E. J. North, L. Yang, R. E. Lee, A. Han, B. Williams, D. Charnuska, K. Coleman, K. Lewis & M. D. LaFleur, (2014) In Vitro and In Vivo Activities of HPi1, a Selective Antimicrobial against Helicobacter pyloriAntimicrobial Agents and Chemotherapy 58: 3255-3260.

Conlon, B. P., E. S. Nakayasu, L. E. Fleck, M. D. LaFleur, V. M. Isabella, K. Coleman, S. N. Leonard, R. D. Smith, J. N. Adkins & K. Lewis, (2013) Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503: 365-370.

Michael LaFleur, Sun L., Keating J., Lister, I., Nantel A., Long L., Ghannoum M., North J., Lee R., Coleman K., Dahl T., Lewis K. (2013) Potentiation of Azole Antifungals by 2-adamantanamine. Antimicrob. Agents Chemother. 57(8):3585-92.

Lewis K. (2013) Platforms for antibiotic discovery. Nat Rev Drug Discov  12:371-387.